{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:10:43Z","timestamp":1755216643178,"version":"3.43.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Pre-diagnosis manipulative therapies in patients diagnosed with osteosarcoma can compromise patients\u2019 outcomes. Limited literature exists on the pre-diagnosis non-oncological management of osteosarcoma, especially in resource-limited settings. We described and characterized the practice of pre-diagnosis manipulative therapy at the reference cancer treatment center in Uganda as a first step to improving the quality along the osteosarcoma treatment pathway.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We reviewed the demographic and clinical characteristics, pre-referral management, and outcome of children under 18 years treated for osteosarcoma at the Uganda Cancer Institute between January 2016 and December 2020. Data on pre-diagnosis management were extracted, as well as clinical and disease characteristics and outcome. Descriptive statistics and Kaplan-Meier survival analysis were used.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Nineteen (25.7%) of the 74 children with osteosarcoma in the current study had undergone prior manipulative therapy. The main forms of manipulative therapy were local therapeutic cuttings with the application of local herbs in 6 (31.5%) patients, massaging in 5 (26.3%), attempted incision and drainage in 4 (21.1%), and treatment as a local infection (osteomyelitis or arthritis) in 4 (21.2%). The majority, 15 (78.9%), of the patients who had manipulative therapy were males (X\u00b2\u2009=\u20095.73; p\u2009=\u20090.031). Children who underwent manipulative therapy were referred after a median of 45 days (range 11\u2013139) compared to their counterparts, who were referred after a median of 28 days (range 1\u2013147) (p\u2009=\u20090.012). Patients with manipulative therapy had a metastatic rate of 77.8%, while the rate was 60.4% for those who did not have manipulative therapy. The serum lactate dehydrogenase level was higher in patients who had manipulative therapy compared to those who did not have manipulative therapy (X<jats:sup>2<\/jats:sup>\u2009=\u20093.98; p\u2009=\u20090.046). The median survival was 1.0 year (95% CI 0.8\u20131.3) for patients who underwent prior manipulative therapy and 1.8 years (95% CI 1.4\u20132.2) for those who did not report any form of manipulative therapy (p\u2009=\u20090.961).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Pre-diagnosis manipulative therapies lead to poorer outcomes in patients diagnosed with osteosarcoma, underscoring the need for bridging the quality gap in the osteosarcoma treatment pathway. This should include sensitization of the community and healthcare provider\u2019s, strengthening patient referral pathways, and improved accessibility to cancer treatment centers.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0329688","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T17:35:46Z","timestamp":1754328946000},"page":"e0329688","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the scope and impact of pre-diagnostic manipulative therapy in children and adolescents with osteosarcoma: A retrospective study in Uganda"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3859-349X","authenticated-orcid":true,"given":"Richard","family":"Nyeko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadhil","family":"Geriga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Racheal","family":"Angom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce","family":"Balagadde Kambugu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaques","family":"van Heerden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"pone.0329688.ref001","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11912-021-01053-7","article-title":"Update on osteosarcoma","volume":"23","author":"R Belayneh","year":"2021","journal-title":"Current Oncol Reports"},{"key":"pone.0329688.ref002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4419-0284-9_1","article-title":"The epidemiology of osteosarcoma","volume":"152","author":"G Ottaviani","year":"2009","journal-title":"Cancer Treat Res"},{"issue":"24","key":"pone.0329688.ref003","first-page":"286","article-title":"Cancer treatments: past, present, and future","volume":"18","author":"D Sonkin","year":"2024","journal-title":"Cancer Genet"},{"issue":"3","key":"pone.0329688.ref004","first-page":"105","article-title":"Overview of perspectives on cancer, newer therapies, and future directions","volume":"10","author":"RM Joshia","year":"2024","journal-title":"Oncol Translational Med"},{"key":"pone.0329688.ref005","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3332\/ecancer.2019.961","article-title":"Innovative approaches for cancer treatment: current perspectives and new challenges","volume":"13","author":"C Pucci","year":"2019","journal-title":"eCancer"},{"issue":"16","key":"pone.0329688.ref006","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/j.ejca.2011.05.030","article-title":"Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?","volume":"47","author":"JK Anninga","year":"2011","journal-title":"Eur J Cancer"},{"issue":"23","key":"pone.0329688.ref007","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1002\/cncr.27651","article-title":"Long\u2010term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high\u2010grade, operable osteosarcoma","volume":"118","author":"NM Bernthal","year":"2012","journal-title":"Cancer"},{"issue":"7","key":"pone.0329688.ref008","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S1470-2045(10)70062-0","article-title":"Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects","volume":"11","author":"KA Janeway","year":"2010","journal-title":"Lancet Oncol"},{"issue":"3","key":"pone.0329688.ref009","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.2002.20.3.776","article-title":"Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols","volume":"20","author":"SS Bielack","year":"2002","journal-title":"J Clin Oncol"},{"issue":"1","key":"pone.0329688.ref010","first-page":"19","article-title":"Health seeking behavior among cancer patients attending ocean road cancer institute, Tanzania","volume":"4","author":"MR Kazaura","year":"2007","journal-title":"East African J Public Health"},{"issue":"3","key":"pone.0329688.ref011","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/10781552221078204","article-title":"Health care seeking behaviors and perspective on indigenous palliative care among cancer patients in Kenya","volume":"29","author":"S Cheboi","year":"2022","journal-title":"J Oncol Pharm Pract"},{"issue":"1","key":"pone.0329688.ref012","doi-asserted-by":"crossref","DOI":"10.1186\/s13690-025-01521-7","article-title":"The role of traditional healers along the cancer care continuum in Sub-Saharan Africa: a scoping review","volume":"83","author":"EF Msoka","year":"2025","journal-title":"Arch Public Health"},{"key":"pone.0329688.ref013","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.2147\/CMAR.S251975","article-title":"Traditional and complementary medicine use among adult cancer patients undergoing conventional treatment in Sub-Saharan Africa: A scoping review on the use, safety and risks","volume":"12","author":"AD Mwaka","year":"2020","journal-title":"Cancer Manag Res"},{"issue":"1","key":"pone.0329688.ref014","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-6246-4","article-title":"Local dissemination of osteosarcoma observed after massage therapy: a case report","volume":"19","author":"S Miwa","year":"2019","journal-title":"BMC Cancer"},{"issue":"20","key":"pone.0329688.ref015","first-page":"106443","article-title":"Harnessing traditional medicine and biomarker-driven approaches to counteract Trichostatin A-induced esophageal cancer progression","volume":"31","author":"HR Liu","year":"2025","journal-title":"World J Gastroenterol"},{"issue":"2","key":"pone.0329688.ref016","first-page":"209","article-title":"An example of toxic medicine used in Traditional Chinese Medicine for cancer treatment","volume":"43","author":"H Liu","year":"2023","journal-title":"J Traditional Chinese Med"},{"issue":"4","key":"pone.0329688.ref017","article-title":"Effect of traditional medicine on clinical cancer","volume":"30","author":"H Liu","year":"2020","journal-title":"Biomed J Sci Tech Res"},{"issue":"11","key":"pone.0329688.ref018","first-page":"1580","article-title":"The prognosis for patients with osteosarcoma who have received prior manipulative therapy","author":"P-K Wu","year":"2010","journal-title":"J Bone Joint Surg Br"},{"issue":"5","key":"pone.0329688.ref019","article-title":"Manipulation therapy prior to diagnosis induced primary osteosarcoma metastasis\u2014From clinical to basic research","volume":"9","author":"J-Y Wang","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"pone.0329688.ref020","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1186\/s12885-019-6246-4","article-title":"Local dissemination of osteosarcoma observed after massage therapy: a case report","volume":"19","author":"S Miwa","year":"2019","journal-title":"BMC Cancer"},{"issue":"1","key":"pone.0329688.ref021","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1186\/s12885-024-12786-6","article-title":"The management of osteosarcoma in children and adolescents in a resource-limited setting: quality improvement considerations to improve treatment outcomes","volume":"24","author":"R Nyeko","year":"2024","journal-title":"BMC Cancer"},{"key":"pone.0329688.ref022","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/tropej\/fmv005","article-title":"Patterns of distribution of childhood cancer in Africa","volume":"61","author":"DC Stefan","year":"2015","journal-title":"J Trop Pediatr"},{"key":"pone.0329688.ref023","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"EL Kaplan","year":"1958","journal-title":"J Am Statist Ass"},{"issue":"1","key":"pone.0329688.ref024","article-title":"Identification of the novel exhausted T cell CD8\u2009+\u2009markers in breast cancer","volume":"14","author":"H Liu","year":"2024","journal-title":"Sci Rep"},{"key":"pone.0329688.ref025","doi-asserted-by":"crossref","DOI":"10.3332\/ecancer.2025.1835","article-title":"Challenges of osteosarcoma care in Africa: a scoping review of the burden, management and outcome","volume":"19","author":"OJ Olajugba","year":"2025","journal-title":"eCancer J"},{"issue":"1","key":"pone.0329688.ref026","article-title":"Massage manipulation and progression of osteosarcoma, does it really correlate: a combination of prospective and retrospective cohort study","volume":"13","author":"IWAM Karda","year":"2023","journal-title":"Sci Rep"},{"volume-title":"Misdiagnosis and mistreatment for osteosarcoma: Analysis of cause and its strategy. In: Agarwal M, editor","year":"2012","author":"Y Yao","key":"pone.0329688.ref027"},{"issue":"2","key":"pone.0329688.ref028","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3390\/curroncol31020067","article-title":"Biopsy techniques for musculoskeletal tumors: basic principles and specialized techniques","volume":"31","author":"A Mavrogenis","year":"2024","journal-title":"Curr Oncol"},{"issue":"3","key":"pone.0329688.ref029","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4103\/0019-5413.132491","article-title":"Classification, imaging, biopsy and staging of osteosarcoma","volume":"48","author":"ZS Kundu","year":"2014","journal-title":"IJOO"},{"key":"pone.0329688.ref030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-540-77960-5_1","article-title":"Biopsy of bone and soft tissue tumours: hints and hazards","volume":"179","author":"A Leithner","year":"2009","journal-title":"Recent Results Cancer Res"},{"issue":"8","key":"pone.0329688.ref031","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2106\/00004623-198264080-00002","article-title":"The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors","volume":"64","author":"HJ Mankin","year":"1982","journal-title":"J Bone Joint Surg"},{"key":"pone.0329688.ref032","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2106\/00004623-199605000-00004","article-title":"The hazards of biopsy, revisited: members of musculoskeletal society","volume":"64","author":"HJ Mankin","year":"1996","journal-title":"J Bone Joint Surg"},{"issue":"4","key":"pone.0329688.ref033","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/pbc.25313","article-title":"SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settings","volume":"62","author":"J Parkes","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"pone.0329688.ref034","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijso.2018.04.004","article-title":"Megaprosthesis limb salvage surgery: outcome and challenges in treating advanced bone tumour cases in vast archipelago in Indonesia. A case series","volume":"11","author":"AF Kamal","year":"2018","journal-title":"Int J Surg Open"},{"issue":"12","key":"pone.0329688.ref035","first-page":"547","article-title":"Osteosarcoma: a meta-analysis and review of the literature","volume":"44","author":"JC Friebele","year":"2015","journal-title":"Am J Orthop (Belle Mead NJ)"},{"issue":"2","key":"pone.0329688.ref036","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3390\/cancers14020360","article-title":"Metastatic progression of osteosarcomas: a review of current knowledge of environmental versus oncogenic drivers","volume":"14","author":"GA Odri","year":"2022","journal-title":"Cancers"},{"issue":"19","key":"pone.0329688.ref037","article-title":"Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma","volume":"97","author":"Y Fu","year":"2018","journal-title":"Medicine"},{"issue":"7","key":"pone.0329688.ref038","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00432-014-1644-0","article-title":"Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis","volume":"140","author":"J Chen","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"pone.0329688.ref039","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/030089160409000507","article-title":"Prognostic significance of serum lactate dehydrogenase in osteosarcoma of the extremity: experience at Rizzoli on 1421 patients treated over the last 30 years","volume":"90","author":"G Bacci","year":"2004","journal-title":"Tumori"},{"issue":"11","key":"pone.0329688.ref040","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/jjco\/hyr138","article-title":"The prognosis of patients with primary osteosarcoma who have undergone unplanned therapy","volume":"41","author":"TI Wang","year":"2011","journal-title":"Jpn J Clin Oncol"},{"issue":"11","key":"pone.0329688.ref041","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29311","article-title":"\u201cMoney was the problem\u201d: Caregivers\u2019 self\u2010reported reasons for abandoning their children\u2019s cancer treatment in southwest Uganda","volume":"68","author":"B Atwiine","year":"2021","journal-title":"Pediatric Blood Cancer"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0329688","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T17:36:08Z","timestamp":1754328968000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0329688"}},"subtitle":[],"editor":[{"given":"Xiaoen","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0329688","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2025,8,4]]}}}